Evaluating the Impact of the Intervention of a Pharmacist in the Operating Room on the Appropriate Use of Sterile Medical DeviceS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-23

Study Completion Date

2018-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

assess the impact of the intervention of a clinical pharmacist expert in sterile medical devices

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards

NCT00431483

Bacterial Infections

COMPLETED NA

Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures

NCT02924844

Intensive Care

COMPLETED

Bacterial Contamination of Anaesthetists' Hands by Personal Mobile Phones Used in the Operating Theatre

NCT00416936

Environmental Microbiology Equipment Contamination Personnel, Hospital

COMPLETED

Evaluation of Bacterial Flora Among Operation Theatre Staff at a Tertiary Care Hospital

NCT04089683

Microbial Colonization

COMPLETED

Effect of Chlorhexidine Solution in Preventing Peripheral Venous Catheter Associated-Infection

NCT05441605

Catheter-Associated Infections

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

impact of the intervention of a clinical pharmacist with expertise in sterile medical devices on non-compliances related to the use of sterile medical devices

\- Failure to trace, Lack of product information, absence of product in the operating room

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- The patient must be a member or beneficiary of a health insurance plan.
* The patient is managed for scheduled surgery (full hospitalization or outpatient) in the UDG (Urology Digestive Gynecology) operating room.

Exclusion Criteria

* \- The subject is in a period of exclusion determined by a previous study.
* The subject is under judicial protection.
* The subject (or his/her legal representative) has expressed his/her opposition to participate in the study.
* The patient is undergoing emergency surgery in the UDG (Urology Digestive Gynecology) operating room.
* It is not possible to give informed information about the subject.

Translated with www.DeepL.com/Translator (free version)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No